A Novel Paclitaxel-Loaded Poly(d,l-Lactide-co-glycolide)-tween 80 Copolymer Nanoparticle Overcoming Multidrug Resistance for Lung Cancer Treatment

Xun Yuan,Wenxiang Ji,Si Chen,Yuling Bao,Songwei Tan,Shun Lu,Kongming Wu,Qian Chu
DOI: https://doi.org/10.2147/ijn.s92271
IF: 7.033
2016-01-01
International Journal of Nanomedicine
Abstract:Drug resistance has become a main obstacle for the effective treatment of lung cancer. To address this problem, a novel biocompatible nanoscale package, poly(d,l-lactide-co-glycolide)-Tween 80, was designed and synthesized to overcome paclitaxel (PTX) resistance in a PTX-resistant human lung cancer cell line. The poly(d,l-lactide-co-glycolide) (PLGA)-Tween 80 nanoparticles (NPs) could efficiently load PTX and release the drug gradually. There was an increased level of uptake of PLGA-Tween 80 in PTX-resistant lung cancer cell line A549/T, which achieved a significantly higher level of cytotoxicity than both PLGA NP formulation and Taxol®. The in vivo antitumor efficacy also showed that PLGA-Tween 80 NP was more effective than Taxol®, indicating that PLGA-Tween 80 copolymer was a promising carrier for PTX in resistant lung cancer.
What problem does this paper attempt to address?